Incorporation of in vitro metabolism data and physiologically based pharmacokinetic modeling in a risk assessment for chloroprene

References

• Allen BC, Van Landingham C, Yang Y, Youk AO, Marsh GM, Esmen N, Gentry PR, Clewell HJ, III, Himmelstein MW. 2014. A constrained maximum likelihood approach to evaluate the impact of dose metric on cancer risk assessment: application to b-chloroprene. Reg Tox Pharm. 70(1):203–213.
   PubMed Web of Science ®Google Scholar
• Andersen ME, Clewell HJ, Gargas ML, Smith FA, Reitz RH. 1987. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicol Appl Pharmacol. 87(2):185–205.
   PubMed Web of Science ®Google Scholar
• Andersen ME, Gargas ML, Clewell HJ, III, Severyn KM. 1987. Quantitative evaluation of the metabolic interactions between trichloroethylene and 1,1-dichloroethylene by gas uptake methods. Toxicol Appl Pharmacol. 89(2):149–157.
   PubMed Web of Science ®Google Scholar
• Brown RP, Delp MD, Lindstedt SL, Rhomberg LR, Beliles RP. 1997. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol Ind Health. 13(4):407–484.
   PubMed Web of Science ®Google Scholar
• Baldwin RM, Jewell WT, Fanucchi MV, Plopper CG, Buckpitt AR. 2004. Comparison of pulmonary/nasal CYP2F expression levels in rodents and Rhesus Macaque. J Pharmacol Exp Ther. 309(1):127–136.
   PubMed Web of Science ®Google Scholar
• Barter ZE, Bayliss MK, Beaune PH, Boobis AR, Carlile DJ, Edwards RJ, Houston JB, Lake BG, Lipscomb JC, Pelkonen OR, et al. 2007. Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver. CDM. 8(1):33–45.
   Google Scholar
• Chiu WA, Barton HA, DeWoskin RS, Schlosser P, Thompson CM, Sonawane B, Lipscomb JC, Krishnan KJ. 2007. Evaluation of physiologically based pharmacokinetic models for use in risk assessment. J Appl Toxicol. 27(3):218–237.
   PubMed Web of Science ®Google Scholar
• Clewell HJ, Andersen ME. 1996. Use of physiologically-based pharmacokinetic modeling to investigate individual versus population risk. Toxicology. 111(1–3):315–329.
   PubMed Web of Science ®Google Scholar
• Clewell HJ, Gentry PR, Gearhart JM, Allen BC, Andersen ME. 2001. Comparison of cancer risk estimates for vinyl chloride using animal and human data with a PBPK model. Sci Total Environ. 274(1-3):37–66.
   PubMed Web of Science ®Google Scholar
• Clewell HJ, Jarnot BM. 1994. Incorporation of pharmacokinetics in non-carcinogenic risk assessment: example with chloropentafluorobenzene. Risk Anal. 14(3):265–276.
   PubMed Web of Science ®Google Scholar
• Clewell HJ, Andersen HJ, Blaauboer BJ. 2008. On the incorporation of chemical-specific information in risk assessment. Toxicol Lett. 180(2):100–109.
   PubMed Web of Science ®Google Scholar
• David RM, Clewell HJ, Gentry PR, Covington TR, Morgott DA, Marino DJ. 2006. Revised assessment of cancer risk to dichloromethane II: application of probabilistic methods to cancer risk determination. Reg Tox Pharm. 45(1):55–65.
   PubMed Web of Science ®Google Scholar
• EURL ECVAM Workshop on New Generation of Physiologically-Based Kinetic Models in Risk Assessment 2017. EUR 28794 EN, Publications Office of the European Union, Luxembourg, ISBN 978-92-79-73849-4, PUBSY No. JRC108231.
   Google Scholar
• Haley T. 1978. Chloroprene (2-chloro-1,3-butadiene)—what is the evidence for its carcinogenicity? Clin Toxicol. 13(2):153–170.
   PubMed Web of Science ®Google Scholar
• Himmelstein MW, Carpenter SC, Evans MV, Hinderliter PM, Kenyon EM. 2004. Kinetic modeling of beta-chloroprene metabolism: II. The application of physiologically based modeling for cancer dose response analysis. Toxicol Sci. 79(1):28–37.
   PubMed Web of Science ®Google Scholar
• Himmelstein MW, Carpenter SC, Hinderliter PM. 2004. Kinetic modeling of beta-chloroprene metabolism: I. In vitro rates in liver and lung tissue fractions from mice, rats, hamsters, and humans. Toxicol Sci. 79(1):18–27.
   PubMed Web of Science ®Google Scholar
• Himmelstein MW, Gladnick NL, Donner EM, Snyder RD, Valentine R. 2001. In vitro genotoxicity testing of (1-chloroethenyl)oxirane, a metabolite of beta-chloroprene. Chem Biol Interact. 135–136:703–713.
   PubMed Web of Science ®Google Scholar
• Himmelstein MW, Turner MJ, Asgharian B, Bond JA. 1994. Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation. Carcinogenesis. 15(8):1479–1486.
   PubMed Web of Science ®Google Scholar
• Houston JB, Galetin A. 2008. Methods for predicting in vivo pharmacokinetics using data from in vitro assays. CDM. 9(9):940–951.
   Google Scholar
• International Institute of Synthetic Rubber Producers (IISRP). 2009a. β-Chloroprene: in vitro rate constants for metabolism in liver, lung, and kidney microsomes. IISRP-17520-1388. Docket ID No. EPA-HQ-ORD-2009-0217.
   Google Scholar
• International Institute of Synthetic Rubber Producers (IISRP). 2009b. Chloroprene: blood concentration toxicokinetics in female mice by single and repeated inhalation exposure. IISRP-12828-1388. Docket ID No. EPA-HQ-ORD-2009-0217.
   Google Scholar
• Keisler J, Collier Z, Chu E, Sinatra N, Linkov I. 2014. Value of information analysis: the state of application. Environ Syst Decis. 34(1):3–23.
   Google Scholar
• Lorenz J, Glatt HR, Fleischmann R, Ferlinz R, Oesch F. 1984. Drug metabolism in man and its relationship to that in three rodent species: monooxygenase, epoxide hydrolase, and glutathione S-transferase activities in subcellular fractions of lung and liver. Biochem Med. 32(1):43–56.
   PubMedGoogle Scholar
• Marino DJ, Clewell HJ, Gentry PR, Covington TR, Hack CE, David RM, Morgott DA. 2006. Revised assessment of cancer risk to dichloromethane I: Bayesian PBPK and dose-response modeling in mice. Reg Tox Pharm. 45(1):44–54.
   PubMed Web of Science ®Google Scholar
• Medinsky MA, Leavens TL, Csanády GA, Gargas ML, Bond JA. 1994. In vivo metabolism of butadiene by mice and rats: a comparison of physiological model predictions and experimental data. Carcinogenesis. 15(7):1329–1340.
   PubMed Web of Science ®Google Scholar
• Melnick RL, Sills RC, Portier CJ, Roycroft JH, Chou BJ, Grumbein SL, Miller RA. 1999. Multiple organ carcinogenicity of inhaled chloroprene (2-chloro-1,3-butadiene) in F344/N rats and B6C3F1 mice and comparison of dose-response with 1,3-butadiene in mice. Carcinogenesis. 20(5):867–878.
   PubMed Web of Science ®Google Scholar
• National Research Council (NRC). 1987. Pharmacokinetics in risk assessment. Drinking water and health. Vol. 8. Washington (DC): National Academy Press.
   Google Scholar
• Nishimura M, Yaguti H, Yoshitsugu H, Naito S, Satoh T. 2003. Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR. Yakugaku Zasshi. 123(5):369–375.
   PubMed Web of Science ®Google Scholar
• NTP (National Toxicology Program). 1998. Toxicology and carcinogenesis studies of chloroprene (CAS No. 126-99-8) in F344 rats and B6C3F1 mice (inhalation studies). Public Health Service, U.S. Department of Health and Human Services; NTP TR-467. Research Triangle Park (NC): National Institute of Environmental Health Sciences. http://ntp.niehs.nih.gov/ntp/htdocs/LT)rpts/tr467.pdf.
   Google Scholar
• Paini A, Leonard JA, Joossens E, Bessems JGM, Desalegn A, Dorne JL, Gosling JP, Heringa MB, Klaric M, Kliment T, et al. 2019. Next generation physiologically based kinetic (NG-PBK) models in support of regulatory decision making. Comput Toxicol. 9:61–72.
   PubMedGoogle Scholar
• Plugge H, Jaeger RJ. 1979. Acute inhalation of 2-chloro-1,3-butadiene (chloroprene): effects on liver and lung. Toxicol Appl Pharmacol. 50(3):565–572.
   PubMed Web of Science ®Google Scholar
• Ramsey JC, Andersen ME. 1984. A physiological model for the inhalation pharmacokinetics of inhaled styrene monomer in rats and humans. Toxicol Appl Pharmacol. 73(1):159–175.
   PubMed Web of Science ®Google Scholar
• Rostami-Hodjegan A. 2012. Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology. Clin Pharmacol Ther. 92(1):50–61.
   PubMed Web of Science ®Google Scholar
• Schlosser PM, Bond JA, Medinsky MA. 1993. Benzene and phenol metabolism by mouse and rat liver microsomes. Carcinogenesis. 14(12):2477–2486.
   PubMed Web of Science ®Google Scholar
• Scotcher D, Billington S, Brown J, Jones CR, Brown CDA, Rostami-Hodjegan A, Galetin A. 2017. Microsomal and cytosolic scaling factors in dog and human kidney cortex and application for in vitro-in vivo extrapolation of renal metabolic clearance. Drug Metab Dispos. 45(5):556–568.
   PubMed Web of Science ®Google Scholar
• Simmonds A C, Reilly C A, Baldwin R M, Ghanayem B I, Lanza DL, Yost G S, Collins K S, Forkert P G. 2004. Bioactivation of 1,1-dichloroethylene to its epoxide by CYP2E1 and CYP2F enzymes. Drug Metab Dispos. 32(9):1032–1039.
   PubMed Web of Science ®Google Scholar
• Sutherland KM, Edwards PC, Combs TJ, Van Winkle LS. 2012. Sex differences in the development of airway epithelial tolerance to naphthalene. Am J Physiol Lung Cell Mol Physiol. 302(1):L68–81.
   PubMed Web of Science ®Google Scholar
• Thomas RS, Himmelstein MW, Clewell HJ, 3rd, Yang Y, Healy E, Black MB, Andersen ME. 2013. Cross-species transcriptomic analysis of mouse and rat lung exposed to chloroprene. Toxicol Sci. 131(2):629–640.
   PubMed Web of Science ®Google Scholar
• USEPA (Environmental Protection Agency). 2000. Vinyl Chloride: CASRN 75-01-4. Integrated Risk Information System (IRIS): chemical assessment summary. U.S. Environmental Protection Agency; National Center for Environmental Assessment. https://cfpub.epa.gov/ncea/iris/iris_documents/documents/subst/1001_summary.pdf.
   Google Scholar
• USEPA (Environmental Protection Agency). 2010. Toxicological review of chloroprene (CAS No. 126. p. 99–98). In support of summary information on the Integrated Risk Information System (IRIS). Washington (DC): U.S. Environmental Protection Agency. https://cfpub.epa.gov/ncea/iris/iris_documents/documents/toxreviews/0070tr.pdf.
   Google Scholar
• USEPA (Environmental Protection Agency). 2011. Dichloromethane: CASRN 75-09-2. Integrated Risk Information System (IRIS): chemical assessment summary. U.S. Environmental Protection Agency; National Center for Environmental Assessment. https://cfpub.epa.gov/ncea/iris/iris_documents/documents/subst/0070_summary.pdf
   Google Scholar
• Van Winkle LS, Gunderson AD, Shimizu JA, Baker GL, Brown CD. 2002. Gender differences in naphthalene metabolism and naphthalene-induced acute lung injury. Am J Physiol. 282(5):L1122–L1134.
   Google Scholar
• Wambaugh JF, Wetmore BA, Pearce R, Strope C, Goldsmith R, Sluka JP, Sedykh A, Tropsha A, Bosgra S, Shah I, et al. 2015. Toxicokinetic triage for environmental chemicals. Toxicol Sci. 147(1):55–67.
   PubMed Web of Science ®Google Scholar
• Wetmore BA, Wambaugh JF, Allen B, Ferguson SS, Sochaski MA, Setzer RW, Houck KA, Strope CL, Cantwell K, Judson RS, et al. 2015. Incorporating high-throughput exposure predictions with dosimetry-adjusted in vitro bioactivity to inform chemical toxicity testing. Toxicol Sci. 148(1):121–136.
   PubMed Web of Science ®Google Scholar
• World Health Organization/International Programme on Chemical Safety (WHO/IPCS). 2010. Characterization and application of physiologically based pharmacokinetic models in risk assessment. Harmonization Project Document No. 9. Geneva, Switzerland.
   Google Scholar
• Wilson EC. 2015. A practical guide to value of information analysis. Pharmacoeconomics. 33(2):105–121.
   PubMed Web of Science ®Google Scholar
• Yamada T, Kondo M, Miyata K, Ogata K, Kushida M, Sumida K, Kawamura S, Osimitz TG, Lake BG, Cohen SM. 2017. An evaluation of the human relevance of the lung tumors observed in female mice treated with permethrin based on mode of action. Toxicol Sci. 157(2):465–486.
   PubMed Web of Science ®Google Scholar
• Yang Y, Himmelstein MW, Clewell HJ. 2012. Kinetic modeling of b-chloroprene metabolism: probabilistic in vitro–in vivo extrapolation of metabolism in the lung, liver and kidneys of mice, rats and humans. Toxicol in Vitro. 26(6):1047–1055.
   PubMed Web of Science ®Google Scholar
• Yoon M, Campbell JL, Andersen ME, Clewell HJ. 2012. Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results. Crit Rev Toxicol. 42(8):633–652.
   PubMed Web of Science ®Google Scholar
• Yoon M, Madden MC, Barton HA. 2007. Extrahepatic metabolism by CYP2E1 in PBPK modeling of lipophilic volatile organic chemicals: impacts on metabolic parameter estimation and prediction of dose metrics. J Toxicol Environ Health A. 70(18):1527–1541.
   PubMed Web of Science ®Google Scholar